16-88485971-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000319555.8(ZFPM1):c.73G>A(p.Val25Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000552 in 1,612,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000319555.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZFPM1 | NM_153813.3 | c.73G>A | p.Val25Met | missense_variant | 2/10 | ENST00000319555.8 | NP_722520.2 | |
ZFPM1 | XM_011522912.3 | c.211G>A | p.Val71Met | missense_variant | 2/10 | XP_011521214.1 | ||
ZFPM1 | XM_011522914.3 | c.172G>A | p.Val58Met | missense_variant | 2/10 | XP_011521216.1 | ||
ZFPM1 | XM_047433667.1 | c.120G>A | p.Arg40= | synonymous_variant | 2/9 | XP_047289623.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZFPM1 | ENST00000319555.8 | c.73G>A | p.Val25Met | missense_variant | 2/10 | 1 | NM_153813.3 | ENSP00000326630 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152244Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000481 AC: 12AN: 249354Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135408
GnomAD4 exome AF: 0.0000377 AC: 55AN: 1460516Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 24AN XY: 726576
GnomAD4 genome AF: 0.000223 AC: 34AN: 152362Hom.: 0 Cov.: 33 AF XY: 0.000228 AC XY: 17AN XY: 74498
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 08, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at